US 7,320,792 B2 | ||
Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist | ||
Hiroaki Ito, Ashiya (Japan); Kazuyuki Yoshizaki, Ashiya (Japan); Norihiro Nishimoto, Minoh (Japan); Tadamitsu Kishimoto, Tondabayashi (Japan); Shin Shimaoka, Gotenba (Japan); Hidetomo Kitamura, Gotenba (Japan); Masamichi Sugimoto, Gotenba (Japan); and Kenichi Akamatsu, Gotenba (Japan) | ||
Assigned to Chugai Seiyaku Kabushiki Kaisha, Tokyo (Japan) | ||
Appl. No. 10/399,979 PCT Filed Oct. 25, 2001, PCT No. PCT/JP01/09409 § 371(c)(1), (2), (4) Date Apr. 24, 2003, PCT Pub. No. WO02/34292, PCT Pub. Date May 02, 2002. |
||
Claims priority of application No. 2000-325904 (JP), filed on Oct. 25, 2000. | ||
Prior Publication US 2004/0028681 A1, Feb. 12, 2004 | ||
Int. Cl. A61K 39/395 (2006.01) |
U.S. Cl. 424—141.1 [424/143.1] | 3 Claims |
1. A method of treating psoriasis comprising administering an effective amount of an antibody against interleukin-6 (IL-6) receptor to a subject in need thereof, wherein said antibody is monoclonal antibody PM-1 against human IL-6 receptor. |